Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2025 Earnings Call Transcript October 29, 2025
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-1.15.
Operator: Good morning, and welcome to the Ionis Pharmaceuticals, Inc. Third Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the conference over to Mr. Wade Walke, Senior Vice President of Investor Relations, to lead...
